Title: Managing Menopause: Dealing With The Facts
1Managing Menopause Dealing With The Facts
2Womens Top Health Risks and Causes of Death
- Perception
- Breast Cancer 46
- Other Cancer 16
- Heart Disease 4
- AIDS 4
- Uterine/Ovarian 3
- Reality
- Heart Disease 34
- Other Cancers 12
- Lung Cancer 5
- Stroke 8
- Breast Cancer 4
3Chronic Diseases
- Screening can significantly reduce risk of
cancer/heart disease - The current challenge is dealing with nonfatal,
chronic, age-dependent conditions such as
Alzheimer's, osteoporosis, obesity, and
incontinence - Preventive health care should now be aimed at how
a person can spend their many years as functional
and productive ones
4Menopausal Facts
- The time when the body quits making estrogen
- Average age 51
- Genetically determined
- Other factors involved smoking, underweight,
high altitudes, vegetarian - Not related to race, height, or age of first
menses
5Menopausal Symptoms
- Hot Flashes
- Vaginal dryness
- Sleep disorders
- Mood disturbances
6Hot Flashes
- Most common symptom of menopause
- Affects 68-93 of women
- Symptoms usually last 6 months to 5 years
- Primary reason women seek medical treatment
- 25 remain symptomatic for 5 years
7Severity of Reported Hot Flashes
- Severe 51
- Moderate 33
- Mild 16
- Symptoms decrease with time
8Hot Flashes Treatment
- Estrogen clearly the most successful (90)
- Decrease night sweats
- Decrease periods of wakefulness
- Increase REM sleep
- Stabilize mood
9Alternative Therapies for Managing Hot Flashes
Phytoestrogens
- Soy protein may decrease hot flashes
- Limited studies, mixed results
- Must be taken as pure soy protein
- No long term studies to show safety
- Dose is 20 grams pure soy protein once or twice
daily
10Alternative Therapies for Managing Hot Flashes
Red Clover
- One study showed 44 reduction
- Dose is 80 mg
- No long term studies
11Alternative Therapies for Managing Hot Flashes
Black Cohosh
- Short term studies show reduction by 70
- Dose is variable
- No study beyond 6 months
12Alternative Therapies for Managing Hot Flashes
SSRIs
- Selective serotonin reuptake inhibitors
- Decrease hot flashes by 50
- Effexor and Paxil the most well studied
- Reasonable option for women with breast cancer
13Alternative Therapies for Managing Hot Flashes
Progesterone
- High dose progesterone reduces hot flashes by 25
85 - High doses associated with weight gain
- Topical progesterone has not been well studied
- Topical absorption is variable
14Alternative Medicine
- 42 of adults in 1998 used some form of
alternative medicine - 60 or 12 million paid cash
- 40 of patients do not inform their doctors
- Not regulated by the FDA
- Ingredients are not tested
- No scientific proof of benefits
15Vaginal Dryness
- A very common complaint
- Generalized daily discomfort
- May result in pain with intercourse
- Primary treatment is oral or vaginal estrogen
- If fearful of systemic estrogen vaginal route
effective with no major side effects - Benefits noted in 2-4 weeks
16Osteoporosis
- 13-18 of Caucasian postmenopausal females have
osteoporosis - 30-50 have osteopenic
- 1998 1.5 million osteoporosis related fractures
- 13 billion dollars in health care services
17Osteoporosis
- Peak bone density is reached at around age 30
- 0.7 decline per year after that
- Potentially 5 per year for spinal bone following
menopause
18Risk Factors for Osteoporosis Nonmodifiable
- Nonmodifiable
- Personal history
- Fracture in a first-degree relative
- Caucasian race
- Advanced age
- Female sex
- Dementia
- Poor health
19Risk Factors for Osteoporosis Modifiable
- Cigarette smoking
- Low body weight
- Estrogen deficiency
- Low calcium intake
- Alcoholism
- Impaired eyesight
- Recurrent falls
- Inadequate physical activity
20Treatment of Osteoporosis with Estrogen
- Decreases fractures by 50 60 in arm and hip
fractures - Decreases up to 80 of vertebral compression
fractures - Requires beginning within 5 years of menopause
- Protective effect lost rapidly after therapy
ended
21Alternative Therapies for the Treatment of
Osteoporosis Bisphosphonates
- Binds to bone to prevent resorption
- Reduces nonvertebral fractures by least 30
- Reduces vertebral fractures by 90
- Can be added to estrogen for combined effects
- Side effects are minimal
- Taken with a full glass of water and remain
upright for 30 minutes without food or beverage - Do not lose effect after discontinued
22Alternatives for Osteoporosis Selective
Estrogen Receptor Modulators (SERMs)
- Synthetic agents
- Beneficial effects on bone and cholesterol while
decreasing the risk of breast cancer and
endometrial cancer - Similar to estrogen in regards to bone
- Full benefits currently under study
- Increase severity of hot flashes
23Colorectal Cancer and Estrogen
- Third most common cancer
- significantly decreases risk with current and
long term use - Most studies show a decrease by 35
- Reason for the benefit is unknown
24Estrogens Benefits and Mental Health
- Sleep disturbances
- Energy
- Cognitive function
- Sexual impairment
- Decreased depression on most depression scores
- Overall increased sense of well-being
25Estrogen and Alzheimer's Disease
- Mixed studies
- Possible decrease in Alzheimer's by 80
- Longer treatment more beneficial
- Estrogen increases cerebral blood flow
- Not helpful once disease is established
26Other Benefits of Estrogen
- Less risk of diabetes
- Decreased body fat
- Decreased arthritis
- Decreased tooth loss by 25
- Decreased vision and hearing loss
27Estrogens Types, Delivery Systems, and Regimens
- There are a variety of estrogens
- Primarily estradiol and estrone
- All estrogens have similar ability
- Impact on bone mineral density
- Hot flashes
28Oral Route Advantages
- Most common
- Must be absorbed through the GI tract
- Increases HDL cholesterol
- Decreases LDL cholesterol
- Decreases some blood clotting factors
- These have been shown to decrease the risk of
cardiovascular disease
29Oral Route Disadvantages
- Increase in triglycerides
- Larger doses required than the patch
- Small risk of GI irritation and nausea
- Increases plasminogen (a blood clotting factor)
30Patch Advantages
- Once or twice per week
- Good choice for those who cannot take pills
- No impact on triglyceride levels
- Equal to oral forms in regards to bone protection
- Potentially safer with a steady state release
31Patch Disadvantages
- Occasional rash from adhesive
- May require progesterone
- Combination estrogen/progesterone patch is larger
than the estrogen patch
32Estrogen Vaginal route
- Easily absorbed for local therapy
- Effective for vaginal dryness and painful
intercourse - Three options for vaginal route exist
- Creams messy, dosing less precise, absorbed
systemically - Tablets twice weekly, minimal absorption
- Vaginal ring 3 month dosing
33Contraindications to Hormone Therapy
- Pregnancy
- Breast cancer
- Estrogen-dependent cancer
- Abnormal genital bleeding
- Blood clots
- Active liver disease
34Estrogen and Blood Clots
- A twofold increase in the risk of blood clots
with hormone therapy - Confined to the first 2 years
- Amounts to an increase of 1.5/10,000 per year
- Risk of death is very low
35The Womens Health Initiative
- Exaggerated in the popular media
- Caused fear and confusion in American women
- No one study has changed the publics opinion in
gynecology
36WHI and Breast Cancer
- Cited an increased of 26
- 8/10,000 cases per year
- Was not statistically significance
- The estrogen only group was not stopped
prematurely because of an increased risk - It takes 10 years for a malignant cell to become
clinically detectable at 1 cm - Increased risk in years 4 and 5 consistent with
hormonal stimulation of preexisting tumors
37Breast cancer
- Over 50 100 studies linking hormone therapy and
breast cancer - Only a few studies shown a small increased risk
- Ever use 1.14
- Current use 1.24
- Past use 1.07
- No study links hormone therapy with a positive
family history
38Mortality from breast cancer when using HRT at
the time of diagnosis
- The majority of studies have shown a decreased
risk of dying from breast cancer when on HRT - Breast cancer in users of HRT appear to be
different compared to nonusers - Smaller tumor size
- More differentiated
- Less spread to lymph nodes
- Less likely to be invasive
39WHI and Cardiovascular Disease
- WHI was labeled as a primary prevention trial
- Debated by average of the participants
- 45 were in their 60s
- 21 in their 70s
- Implies that the majority of patients were
already at risk
40WISDOM
- International British study involving 34,000
women ends this year to evaluate HRT and it
effects on - Fatal and nonfatal ischemic heart disease
- Major osteoporotic fracture
- Breast cancer
- Quality of life
- The study was not stopped prematurely because the
researches felt that the WHI study was not
statistically significant
41Estrogen Risks/Benefits
- Evidence to show a small increased risk of
cardiovascular disease and breast cancer - Evidence to support HRT in decreasing symptoms
such as hot flashes, vaginal dryness, and sleep
problems - Evidence to show HRT decreases osteoporosis and
colorectal cancer - Evidence to support other benefits of HRT
including improved cognition, decreased
Alzheimer's disease, urinary incontinence, and
tooth loss
42Reasonable Alternatives
- Hot flashes herbal regimens may help, SSRIs
have shown significant benefit - Vaginal dryness vaginal rings, creams and
tablets with minimal absorption - Osteoporosis SERMs and Bisphosphonates decrease
bone loss - Cardiovascular disease cholesterol lowering
agents statins decrease the risk of
cardiovascular disease
43Conclusion
- Determine what is important to you
- Evaluating your goals may make more options
available - Focus on the best way to live a healthy and
active life